Earendil Labs

Transforming protein therapeutics discovery through next-generation AI

Biotech & Life Sciences

Sector

Seed

Stage

B2B SaaS

Model

01Company Overview

Transforming protein therapeutics discovery through next-generation AI. Earendil Labs develops AI platforms that transform protein therapeutics R&D and applies them to discover and develop novel drugs.

02Backed By1 investor

DDimension→

03Recent Activity

Is this your company? Claim your profile

FROM Dimension

Dimension participated in a $787M Series C for AI-powered cancer and immune drugmaker Earendil Labs.

INVESTMENT·biopharmadive.com

JUL 2026

FROM Dimension

Participated in Earendil Labs' $787M financing round. Earendil Labs is an AI-powered biologics discovery and development platform.

INVESTMENT·prnewswire.com

MAR 20, 2026

04Similar Companies

NL

Numerion Labs

Biotech & Life Sciences

→

CT

Congruence Therapeutics

Biotech & Life Sciences

→

TB

Tamarind Bio

Biotech & Life Sciences

→

RP

Recursion Pharmaceuticals

Biotech & Life Sciences

→

05Startup DNA

9

signals

Sectors
Business Model
Technology